Multiple Response Elements and Differential p53 Binding Control Perp Expression during Apoptosis

Molecular Cancer Research

Volumn 1, Issue 14, 2003, Pages 1048-1057

  Reczek, Elizabeth E ^a   Flores, Elsa R ^a   Tsay, Alice S ^a   Attardi, Laura D ^b   Jacks, Tyler ^a,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA RESPONSIVE ELEMENT; FIBROBLAST; GENE LOCATION; INTRON; MITOSIS INHIBITION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL CYCLE; CELLS, CULTURED; CHROMATIN; FIBROBLASTS; GENE EXPRESSION REGULATION; MEMBRANE PROTEINS; MICE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RESPONSE ELEMENTS; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0346729917     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
2. Giaccia, A. J. and Kastan, M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev., 12: 2973-2983, 1998.
3. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature, 379: 88-91, 1996.
4. Guidos, C. J., Williams, C. J., Grandal, I., Knowles, G., Huang, M. T., and Danska, J. S. V(D)J recombination activates a p53-dependent DNA damage checkpoint in SCID lymphocyte precursors. Genes Dev., 10: 2038-2054, 1996.
5. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
6. 1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev., 10: 934-947, 1996.
7. Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., and Reid, B. J. A p53-dependent mouse spindle checkpoint. Science, 267: 1353-1356, 1995.
8. Di Leonardo, A., Khan, S. H., Linke, S. P., Greco, V., Seidita, G., and Wahl, G. M. DNA re-replication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res., 57: 1013-1019, 1997.
9. Minn, A. J., Boise, L. H., and Thompson, C. B. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev., 10: 2621-2631, 1996.
10. Vousden, K. H. and Lu, X. Live or let die: the cell's response to p53. Nat. Rev. Cancer, 2: 594-604, 2002.
11. Khanna, K. K. and Jackson, S. P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet., 27: 247-254, 2001.
12. Smith, M. L. and Seo, Y. R. p53 regulation of DNA excision repair pathways. Mutagenesis, 17: 149-156, 2002.
13. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and Van Dyke, T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78: 703-711, 1994.
14. Lin, J., Wu, X., Chen, J., Chang, A., and Levine, A. J. Functions of the p53 protein in growth regulation and tumor suppression. Cold Spring Harbor Symp. Quant. Biol., LIX: 215-233, 1995.
15. Hupp, T. R. and Lane, D. P. Allosteric activation of latent p53 tetramers. Curr. Biol., 4: 865-875, 1994.
16. Jayaraman, J. and Prives, C. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell, 81: 1021-1029, 1995.
17. Cho, Y., Gorina, S., Jeffrey, P. D., and Pavletich, N. P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science, 265: 346-355, 1994.
18. Jeffrey, P. D., Gorina, S., and Pavletich, N. P. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science, 267: 1498-1502, 1995.
19. Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., and Tanaka, N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science, 288: 1053-1058, 2000.
20. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
21. Okamoto, K. and Beach, D. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J., 13: 4816-4822, 1994.
22. Zambetti, G. P., Bargonetti, J., Walker, K., Prives, C., and Levine, A. J. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev., 6: 1143-1152, 1992.
23. Miyashita, T. and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80: 293-299, 1995.
24. Comer, K. A., Dennis, P. A., Armstrong, L., Catino, J. J., Kastan, M. B., and Kumar, C. C. Human smooth muscle a-actin gene is a transcriptional target of the p53 tumor suppressor protein. Oncogene, 16: 1299-1308, 1998.
25. Thornborrow, E. C., Patel, S., Mastropietro, A. E., Schwartzfarb, E. M., and Manfredi, J. J. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes. Oncogene, 21: 990-999, 2002.
26. Ren, C., Li, L., Goltsov, A. A., Timme, T. L., Tahir, S. A., Wang, J., Garza, L., Chinault, A. C., and Thompson, T. C. mRTVP-1, a novel p53 target gene with proapoptotic activities. Mol. Cell. Biol., 22: 3345-3357, 2002.
27. Nakano, K. and Vousden, K. H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell, 7: 683-694, 2001.
28. Zauberman, A., Flusberg, D., Haupt, Y., Barak, Y., and Oren, M. A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res., 23: 2584-2592, 1995.
29. Wu, X., Bayle, J. H., Olson, D., and Levine, A. J. The p53-mdm-2 autoregulatory feedback loop. Genes Dev., 7: 1126-1132, 1993.
30. el-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., and Vogelstein, B. Definition of a consensus binding site for p53. Nat. Genet., 1: 45-49, 1992.
31. Ko, L. J. and Prives, C. p53: puzzle and paradigm. Genes Dev., 10: 1054-1072, 1996.
32. Attardi, L. D., Lowe, S. W., Brugarolas, J., and Jacks, T. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J., 15: 3693-3701, 1996.
33. Chao, C., Saito, S., Kang, J., Anderson, C. W., Appella, E., and Xu, Y. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J., 19: 4967-4975, 2000.
34. Jimenez, G. S., Nister, M., Stommel, J. M., Beeche, M., Barcarse, E. A., Zhang, X. Q., O'Gorman, S., and Wahl, G. M. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat. Genet., 26: 37-43, 2000.
35. Friedlander, P., Haupt, Y., Prives, C., and Oren, M. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol., 16: 4961-4971, 1996.
36. Ishioka, C., Englert, C., Winge, P., Yan, Y. X., Engelstein, M., and Friend, S. H. Mutational analysis of the carboxy-terminal portion of p53 using both yeast and mammalian cell assays in vivo. Oncogene, 10: 1485-1492, 1995.
37. Kobayashi, T., Consoli, U., Andreeff, M. Shiku, H., Deisseroth, A. B., and Zhang, W. Activation of p21WAF1/Cip1 expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis. Oncogene, 11: 2311-2316, 1995.
38. Rowan, S., Ludwig, R. L., Haupt, Y., Bates, S., Lu, X., Oren, M., and Vousden, K. H. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J., 15: 827-838, 1996.
39. Sabbatini, P., Chiou, S. K., Rao, L., and White, E. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol., 15: 1060-1070, 1995.
40. Ryan, K. M. and Vousden, K. H. Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest. Mol. Cell. Biol., 18: 3692-3698, 1998.
41. Ludwig, R. L., Bates, S., and Vousden, K. H. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol. Cell. Biol., 16: 4952-4960, 1996.
42. Flores, E. R., Tsai, K. Y., Crowley, D., Sengupta, S., Yang, A., McKeon, F., and Jacks, T. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature, 416: 560-564, 2002.
43. Shikama, N., Lee, C. W., France, S., Delavaine, L., Lyon, J., Krstic-Demonacos, M., and La Thangue, N. B. A novel cofactor for p300 that regulates the p53 response. Mol. Cell, 4: 365-376, 1999.
44. Samuels-Lev, Y., O'Connor, D. J., Bergamaschi, D., Trigiante, G., Hsieh, J. K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., and Lu, X. ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell, 8: 781-794, 2001.
45. Debbas, M. and White, E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev., 7: 546-554, 1993.
46. Lowe, S. W. and Ruley, H. E. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev., 7: 535-545, 1993.
47. Hermeking, H. and Eick, D. Mediation of c-Myc-induced apoptosis by p53. Science, 265: 2091-2093, 1994.
48. Qin, X. Q., Livingston, D. M., Kaelin, W. G., Jr., and Adams, P. D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 91: 10918-10922, 1994.
49. Wagner, A. J., Kokontis, J. M., and Hay, N. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev., 8: 2817-2830, 1994.
50. Wu, X. and Levine, A. J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA, 91: 3602-3606, 1994.
51. Soengas, M. S., Alarcon, R. M., Yoshida, H., Giaccia, A. J., Hakem, R., Mak, T. W., and Lowe, S. W. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science, 284: 156-159, 1999.
52. Attardi, L. D., Reczek, E. E., Cosmas, C., Demicco, E. G., McCurrach, M. E., Lowe, S. W., and Jacks, T. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev., 14: 704-718, 2000.
53. Resnick-Silverman, L., St Clair, S., Maurer, M., Zhao, K., and Manfredi, J. J. Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev., 12: 2102-2107, 1998.
54. Mundt, M., Hupp, T., Fritsche, M., Merkle, C., Hansen, S., Lane, D., and Groner, B. Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential. Oncogene, 15: 237-244, 1997.
55. Hupp, T. R., Meek, D. W., Midgley, C. A., and Lane, D. P. Regulation of the specific DNA binding function of p53. Cell, 71: 875-886, 1992.
56. Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E., and Shay, J. W. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol., 12: 2866-2871, 1992.
57. Flatt, P. M., Tang, L. J., Scatena, C. D., Szak, S. T., and Pietenpol, J. A. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. Mol. Cell. Biol., 20: 4210-4223, 2000.
58. Takahashi, T., Carbone, D., Nau, M. M., Hida, T., Linnoila, I., Ueda, R., and Minna, J. D. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res., 52: 2340-2343, 1992.
59. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev., 9: 935-944, 1995.
60. Zauberman, A., Lupo, A., and Oren, M. Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites. Oncogene, 10: 2361-2366, 1995.
61. Vousden, K. H. p53: death star. Cell, 103: 691-694, 2000.
62. Qian, H., Wang, T., Naumovski, L., Lopez, C. D., and Brachmann, R. K. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites. Oncogene, 21: 7901-7911, 2002.
63. Inga, A., Storici, F., Darden, T. A., and Resnick, M. A. Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence. Mol. Cell. Biol., 22: 8612-8625, 2002.
64. McCurrach, M. E., Connor, T. M., Knudson, C. M., Korsmeyer, S. J., and Lowe, S. W. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA, 94: 2345-2349, 1997.
65. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science, 249: 912-915, 1990.
66. Kern, S. E., Pietenpol, J. A., Thiagalingam, S., Seymour, A., Kinzler, K. W., and Vogelstein, B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science, 256: 827-830, 1992.